tiprankstipranks
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market
Holding RAPP?
Track your performance easily

Rapport Therapeutics, Inc. (RAPP) Financial Statements

19 Followers

Rapport Therapeutics, Inc. Financial Overview

Rapport Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Rapport Therapeutics, Inc. is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Mar 24Dec 23
Income Statement-
Total Revenue---
Gross Profit---
EBIT$ -17.54M$ -22.67M-
EBITDA$ -17.16M$ -22.52M-
Net Income Common Stockholders$ -17.54M$ -22.67M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 320.66M$ 193.24M$ 147.48M
Total Assets$ 331.14M$ 206.29M$ 155.42M
Total Debt$ 1.65M$ 686.00K$ 670.00K
Net Debt$ -319.01M$ -192.56M$ -146.81M
Total Liabilities$ 8.03M$ 11.18M$ 14.48M
Stockholders Equity$ 323.11M$ 195.11M$ 140.94M
Cash Flow-
Free Cash Flow$ -16.55M$ -18.69M-
Operating Cash Flow$ -16.41M$ -17.61M-
Investing Cash Flow$ -53.04M$ -41.93M-
Financing Cash Flow$ -1.39M$ 63.66M-
Currency in USD

Rapport Therapeutics, Inc. Earnings and Revenue History

Rapport Therapeutics, Inc. Debt to Assets

Rapport Therapeutics, Inc. Cash Flow

Rapport Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis